Additionally, dual inhibition or degradation of AR and ER is not sufficient, in most models, to radiosensitise AR+/ER+ breast cancer cells in vitro suggesting that these receptors may not be compensating for each other when co-expressed. Here, ESR1 is linked to breast carcinoma.